The discovery of the countercurrent multiplier system as the mechanism responsible for the concentration and dilution of the urine has provided a framework for the identification of the site of action of diuretic drugs. Agents that act at a single anatomic site in the nephron can be expected to alter the pattern of urine flow in a predictable way. A drug that acts solely in the proximal convoluted tubule, by causing the delivery of increased amounts of filtrate to the loop of Henle and the distal convolution, would augment the clearance of solute-free water (CH2o) during water diuresis and the reabsorption of solute-free water (TCHO) during water restriction. In contrast, drugs that inhibit sodium reabsorption in Henle's loop would impair both CHSo and TCHO. Finally, drugs that act only in the distal tubule would reduce CHSo but not TcH2o (1) .
It is possible, however, that a diuretic drug might inhibit sodium reabsorption at multiple sites. Under such circumstances, localization of the areas of the nephron where the drug acts is far more difficult, since the effects of action in one segment might alter or obscure the effects on another.
A new sulfonamide diuretic, furosemide, 4 -chloro -N -(2-furylmethyl) -5-sulfonylanthranilic acid (2) , offers several advantages in the study of localization of action: a) it is extremely potent, and therefore produces large effects; and b) its duration of action is brief, thereby facilitating multiple studies during a single experiment. A study of furosemide was, therefore, undertaken to ex plore its effects on water excretion during hydration and hydropenia, and on potassium excretion during potassium loading. In addition, the diuretic effect of furosemide was compared to three other sulfonamide diuretics: chlorothiazide, chlorthalidone, and benzhydroflumethiazide.
The conventional sulfonamide diuretics resulted in the excretion of about 10% of filtered sodium and inhibited CQ2o without decreasing TCH2O. In contrast, as much as 38% of filtered sodium was excreted during furosemide diuresis, and both CH20 and TCHSo were inhibited. None of the diuretics had an inhibitory effect on potassium secretion. The effects of the conventional sulfonamide diuretics can be explained by a single site of action distal to the loop of Henle. In contrast, furosemide clearly has a potent effect in the ascending limb of Henle's loop and probably in the proximal convoluted tubule as well.
Methods
A total of 50 experiments was performed on 40 dogs. All dogs were fasted overnight before each study. Mild pentothal anesthesia was induced to facilitate the insertion of an indwelling urethral catheter; the dogs were then allowed to awaken. The experiments were divided as follows.
Water diuresis. In 18 experiments on 13 of the dogs water diuresis was induced by the administration of 50 ml of water per kg body weight via a nasogastric tube and maintained by the continuous infusion of 2.5% dextrose solution at 10 ml per minute. When water diuresis was well established, two to four control urine samples were collected.
Since an increase in sodium excretion during water diuresis results in an increased formation of free water (3) and hence will obscure any inhibitory effect of a drug on this latter function, the normal relationship between osmolar clearance (C.8,) and CH20 was first defined. The increase in Cosm was accomplished in 4 experiments by the infusion of 10 to 20 ml per minute of 0.1 M NaCl. In the remaining 14 experiments the control period was followed by the intravenous administration of 1458 the diuretic drug to be studied-0.5 to 5 mg per kg body weight furosemide (7 experiments), 2 to 5 mg per kg body weight chlorthalidone (3 experiments), 2 mg per kg body weight benzhydroflumethiazide (3 experiments) , and 25 mg per kg body weight chlorothiazide (1 experiment). Urine samples were then collected for several more periods. Preliminary experiments disclosed that *under the conditions of our experiments 0.5 mg furosemide per kg body weight elicited a maximal natriuretic response that was not augmented by a tenfold increase in drug dosage. The amounts of chlorthalidone, benzhydroflumethiazide, and chlorothiazide injected were also doses that produced maximal levels of sodium excretion.
In early experiments the brisk diuresis induced by furosemide appeared to reduce extracellular fluid (ECF) volume and stimulate antidiuretic hormone (ADH), which would influence free water excretion independent of any direct effect of the drug on free water formation. To obviate this possibility ECF volume was replenished during furosemide diuresis by infusing 0.1 M NaCl at a rate that was varied every minute to equal the rate of urine flow, and thereby prevent either underexpansion or overexpansion of extracellular volume.
Hydropenia. In 25 experiments on 22 dogs water was withdrawn 24 hours before each experiment. On the day of the experiment 5 U of vasopressin in oil was injected intramuscularly, followed 2 hours later by 22 mU per kg body weight aqueous vasopressin intravenously and 50 mU per kg per hour subsequently.
To examine critically the effect of the diuretic drugs on the relationship between T'En2o and Cosm, the normal relationship between these two variables was established in each dog for comparison. This was accomplished by infusing 2 to 5%o NaCl solutions at 4 to 10 ml per minute and collecting several periods at a wide range of urine flow. Because of the short duration of furosemide action, it was possible to define the normal relationships of Cosm to TCH},0 in these experiments by commencing the infusion of hypertonic saline following the termination of furosemide action. In the experiments involving the other longer acting diuretics, however, it was necessary to first induce a hypertonic saline diuresis; the diuretic drugs were then given at the termination of the saline diuresis. Furosemide was given in 5 experiments, benzhydroflumethiazide in 5 experiments, chlorthalidone in 5 experiments, and chlorothiazide in 1 experiment. The doses of the diuretic agents were the same as those given during water diuresis. To prevent a fall in TCH2o due to salt depletion (4), 0.9% NaCl was infused at a rate equal to urine flow for the duration of drug action in every experiment. Potassium secretion. The effect of diuretics on tubular secretion of potassium was studied under conditions designed to stimulate maximal secretion, so as to obviate the masking effect of increased sodium delivery and thereby facilitate the detection of any inhibitory influence of the drug. Accordingly, 7 dogs were prepared in the manner described by Berliner, Kennedy, and Hilton (5 (Table  I , experiments 1, 3, 4) . This is also evident in the data of Heidland, Klitsch, and Suzuki in man (9) . This temporary increase in GFR does not appear to be a pharmacologic effect of the drug, but is more likely a result of washout of inulin in the dead space of the urinary tract. In all experiments during water diuresis (Table II) , the GFR remained constant or fell during the first diuretic period after furosemide administration.
In only 2 of 11 studies (Table I , experiments 6 and 8) did the other sulfonamide diuretics produce a rise in GFR during antidiuresis. In the remaining 9 studies the GFR remained unchanged or fell. Doubtless the smaller diuretic action of these agents as compared with furosemide elicited less a rate sufficient to replenish urinary losses, and of a washout effect. In all 7 studies involving blood pressure was constant throughout.
chlorthalidone, chlorothiazide, and benzhydrofluPotency. When potency was expressed in terms methiazide during water diuresis (Table II) GFR of the per cent of the glomerular filtrate and the filwas constant or fell during the initial diuretic pe-tered sodium excreted under the impact of a diuriod. There was a tendency with all the diuretics retic drug, furosemide clearly was the most postudied, both during antidiuresis and water diu-tent diuretic (Table III) . Furosemide resulted in resis, for the GFR to fall during the later periods. the excretion of an average of approximately 20%o This could not be entirely attributed to salt deple-of the filtered sodium, whereas the average natriution or hypotension, since salt was administered at resis with the other diuretics was only 10%. Al- (Figure 3) . Potassium secretion. In dogs prefed KCl for 1 week, net tubular secretion of potassium was produced by the infusion of isotonic potassium ferrocyanide. In all experiments the rise in sodium excretion following diuretic administration was accompanied by an increase in potassium excretion. In Table V Figure 4) . Similarly, chlorothiazide and chlorthalidone had no effect on the relation between potassium and sodium excretion ( Figure 5) . None of the diuretics, therefore, exhibited any inhibitory effects on potassium excretion.
Acid excretion. In 5 dogs undergoing water diuresis, the administration of furosemide resulted in an increased excretion of ammonium ion and titratable acid, and a fall in urine pH, with the exception of one experiment where the urine pH rose slightly ( Figure 6 ). There that it has a different locus of action. Furosemide inhibited free water excretion by 50 to 60%o and markedly reduced free water reabsorption, whereas the other sulfonamide diuretics inhibited CHO but had no effect on T7C2o0 Since the ascending limb of Henle's loop is the only site in the nephron where sodium reabsorption contributes to both CH20 and TCH20, these results clearly establish this segment as a major site of furosemide action. In contrast, the absence of any inhibitory effect on TCH2o by the other diuretics suggests that they have no effect on the ascending limb of Henle's loop.
The ability of some diuretics such as chlorothiazide to inhibit CH20 without any effect on TCH20 (11) and of other diuretics such as furosemide to inhibit both CH20 and TCH20 suggests that there are two functionally distinct diluting segments. One diluting site, which may be termed the "medullary" diluting segment, occurs in the ascending limb of Henle's loop, contributes both to Tc112o and CH20, and is clearly inhibited by furosemide. A second diluting site, the "cortical" diluting segment, contributes only to CH20 and is inhibited by agents such as chlorothiazide ( 11 ) . The fact that diuretics which act on the cortical diluting segment do not inhibit potassium and hydrogen secretion (Table V) suggests two possibilities concerning sodium reabsorption in the distal nephron. One possibility is that two different mechanisms mediate sodium reabsorption throughout the distal tubule, one system linking Na+ and Cl-reabsorption and concerned with urinary dilution, and a second involved with the reabsorption of Na+ in exchange for K+ and H+, a process that would not alter urine osmotic pressure. An alternative possibility is that the sodium reabsorption concerned with urine dilution is located in a different anatomical site from that concerned with exchange. Micropuncture studies furnish strong support for this latter proposal. Potassium secretion appears to begin at the accessible portion of the distal convolution (just distal to the macula densa) and continues throughout the distal tubule (12) . This area of the nephron does not appear to contribute to urinary dilution, since Gottschalk has shown that during water diuresis the fluid entering this segment is already maximally dilute with little or no further dilution along the remaining portion (13) . These findings support the proposal that the cortical portion of the distal nephron can be distinguished into a proximal segment (from the cortico-medullary junction to the macula densa) concerned with sodium chloride reabsorption and, therefore, urine dilution (cortical diluting segment), and a distal segment concerned with exchange. Our results also establish that not only chlorothiazide but also benzhydroflumethiazide and chlorthalidone reduce CH20 without influencing TcH20 or K+ secretion and therefore probably act on the cortical diluting segment.
Like chlorothiazide, chlorthalidone, and benzhydroflumethiazide, furosemide might also inhibit sodium transport in the cortical diluting segment. The absence of any inhibitory effect of furosemide on K+ secretion is evidence against action in the later distal tubule.
It is doubtful, however, whether an action in the thick ascending limb alone could account for the enormous magnitude of furosemide diuresis, a finding that raises the question of an inhibitory effect in the proximal tubule as well. This is suggested by a rise in CH2o noted very early in the course of furosemide diuresis (Table IV , experiment 2). Two lines of evidence can be used to establish more convincingly a proximal tubular effect.
One means of assessing proximal tubular action has been to examine the effects of the drug during water diuresis. If it is assumed that during maximal water diuresis relatively little water is reabsorbed in the distal water-impermeable portions of the nephron,1 then the final urine volume can be considered a rough approximation of the volume entering the water-impermeable segments. Inhibition of sodium reabsorption in this distal waterimpermeable segment would then be expected to increase Cosm and decrease CH2o but have little effect on urine flow. The finding in the present studies, therefore, that furosemide markedly increased urine volume in water diuresis (up Earlier studies on chlorothiazide demonstrated that this drug would inhibit CH2O (1, 11) but would not reduce TCH2O (1, 11, 16) that the former acted on the cortical, the latter on the medullary, diluting segment. In addition, a proximal tubular site of action could not be excluded (18) .
It is concluded, therefore, that although furosemide is a potent inhibitor of sodium reabsorption, it has no inhibitory effect on either potassium or hydrogen ion secretion. Its maj or sites of action appear to be the proximal tubule and the ascending limb of Henle's loop.
Summary
The effects of a new diuretic, furosemide, were investigated and compared to other sulfonamide diuretics. In most instances there was a reduction in glomerular filtration rate that was not caused by salt depletion or hypotension. Furosemide in-hibited both solute-free water clearance (CH2o) and the reabsorption of solute-free water (TCH20), indicating a marked effect in the ascending limb of the loop of Henle. During antidiuresis as much as 38% of the glomerular filtrate was excreted, strongly suggesting a site of action in the proximal tubule. Finally, there was no inhibition of potassium secretion. The other sulfonamide diuretics, however, inhibited CH2, but not TCH2o, indicating an effect only on a cortical diluting segment; since no more than 10% of the glomerular filtrate was excreted, an action on the proximal tubules could not be identified.
CH2o during furosemide diuresis was depressed from a maximal control value of 15 ml per minute to about 9 ml per minute where it remained constant despite great increases in sodium excretion, thereby exhibiting the characteristics of a tubular maximum. This explains why furosemide and other diuretics can depress, leave unchanged, or augment CH2o, depending on whether the control level of CH2o is above, at, or below the maximal CH2o during drug action.
